ATYR
aTYR PHARMA INC
Company overview
- Market capitalization
- $29.20M
- Employees
- 58
- Latest publication
- 2026-09-29
About aTYR PHARMA INC
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; Phase 2 clinical trial to treat Sarcoidosis and systemic sclerosis- interstitial lung disease (ILDs); and treatment of other ILDs, such as chronic hypersensitivity pneumonitis (CHP) and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 235,000USD |
| Cost Of Revenue | 394,000USD | 394,000USD | 387,000USD | 383,000USD | 12,228,000USD | 388,000USD | 383,000USD | 770,000USD |
| Gross Profit | -394,000USD | -394,000USD | -387,000USD | -383,000USD | -12,228,000USD | -388,000USD | -383,000USD | 235,000USD |
| Research Development | 7,317,000USD | 10,891,000USD | 15,384,000USD | 11,814,000USD | 12,228,000USD | 14,807,000USD | 13,973,000USD | 13,364,000USD |
| Selling General Administrative | 4,119,000USD | 3,905,000USD | 4,929,000USD | 3,959,000USD | 3,592,000USD | 3,336,000USD | 3,342,000USD | 3,507,000USD |
| Total Operating Expenses | 11,042,000USD | 14,796,000USD | 20,313,000USD | 15,773,000USD | 3,592,000USD | 18,143,000USD | 17,315,000USD | 16,871,000USD |
| Operating Income | -11,436,000USD | -14,796,000USD | -20,313,000USD | -15,773,000USD | -15,820,000USD | -18,143,000USD | -17,315,000USD | -16,636,000USD |
| Income Before Tax | -10,791,000USD | -13,964,000USD | -19,532,000USD | -14,881,000USD | -14,968,000USD | -17,261,000USD | -16,306,000USD | -15,487,000USD |
| Net Income | -10,791,000USD | -13,963,000USD | -19,531,000USD | -14,880,000USD | -14,967,000USD | -17,259,000USD | -16,306,000USD | -15,491,000USD |
| Net Income From Continuing Ops | -10,792,000USD | -13,964,000USD | -19,532,000USD | -14,881,000USD | -14,968,000USD | -17,261,000USD | -16,306,000USD | -15,487,000USD |
| Ebit | -10,791,000USD | -13,964,000USD | -19,532,000USD | -14,881,000USD | -14,968,000USD | -17,261,000USD | -16,306,000USD | -15,487,000USD |
| Ebitda | -10,397,000USD | -13,570,000USD | -19,145,000USD | -14,498,000USD | -14,793,000USD | -16,873,000USD | -15,923,000USD | -14,717,000USD |
| Depreciation And Amortization | 394,000USD | 394,000USD | 387,000USD | 383,000USD | 175,000USD | 388,000USD | 383,000USD | 770,000USD |
| Reconciled Depreciation | 394,000USD | 394,000USD | 387,000USD | 383,000USD | -1,000USD | 388,000USD | 383,000USD | 770,000USD |
| Total Other Income Expense Net | 645,000USD | 832,000USD | 781,000USD | 892,000USD | 852,000USD | 882,000USD | 1,009,000USD | 1,149,000USD |
| Minority Interest | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 1,000USD | 2,000USD | 0USD | -4,000USD |
| Unclassified Operating Expenses | — | — | — | — | -12,228,000USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 383,000USD | 770,000USD |
| Income Tax Expense | — | — | — | — | — | — | -1USD | 4,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 235,000USD | 353,000USD | 0USD | — | — | — | — | — |
| Cost Of Revenue | 1,540,000USD | 2,741,000USD | 1,304,000USD | 746,000USD | 713,000USD | 900,000USD | — | — |
| Gross Profit | 235,000USD | 353,000USD | -1,304,000USD | -746,000USD | -713,000USD | -900,000USD | — | — |
| Research Development | 54,372,000USD | 42,293,000USD | 23,264,000USD | 20,385,000USD | 30,067,000USD | 44,246,000USD | 34,504,000USD | 16,777,000USD |
| Selling General Administrative | 13,777,000USD | 12,979,000USD | 10,751,000USD | — | — | — | 13,112,000USD | 6,777,000USD |
| Total Operating Expenses | 68,149,000USD | 55,272,000USD | 32,711,000USD | 32,074,000USD | 46,432,000USD | 58,440,000USD | 47,616,000USD | 23,554,000USD |
| Operating Income | -67,914,000USD | -54,919,000USD | -34,015,000USD | -32,820,000USD | -47,145,000USD | -59,340,000USD | -47,616,000USD | -23,554,000USD |
| Income Before Tax | -64,022,000USD | -50,397,000USD | -33,777,000USD | -34,515,000USD | -48,207,000USD | -57,904,000USD | -47,973,000USD | -24,350,000USD |
| Net Income | -64,023,000USD | -50,389,000USD | -33,768,000USD | -34,515,000USD | -48,207,000USD | -57,855,000USD | -47,973,000USD | -24,350,000USD |
| Net Income From Continuing Ops | -64,022,000USD | -50,397,000USD | -33,777,000USD | — | — | — | — | — |
| Ebit | -64,022,000USD | -50,397,000USD | -33,777,000USD | -32,820,000USD | -47,145,000USD | -57,904,000USD | -46,216,000USD | -23,554,000USD |
| Ebitda | -62,482,000USD | -47,656,000USD | -32,473,000USD | -32,074,000USD | -46,432,000USD | -57,004,000USD | -45,347,000USD | -22,725,000USD |
| Depreciation And Amortization | 1,540,000USD | 2,741,000USD | 1,304,000USD | 746,000USD | 713,000USD | 900,000USD | 869,000USD | 829,000USD |
| Reconciled Depreciation | 1,540,000USD | 2,741,000USD | 1,304,000USD | — | — | — | — | — |
| Total Other Income Expense Net | 3,892,000USD | 4,522,000USD | 238,000USD | -1,695,000USD | -1,062,000USD | 1,436,000USD | -357,000USD | -796,000USD |
| Minority Interest | -1,000USD | 8,000USD | 9,000USD | — | — | — | — | — |
| Income Tax Expense | — | -8,000USD | -9,000USD | 1USD | — | -49,000USD | — | — |
| Unclassified Operating Expenses | — | — | -1,304,000USD | 11,689,000USD | 16,365,000USD | 14,194,000USD | — | — |
| Interest Expense | — | — | — | — | — | — | — | 832,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 69,825,000USD | 79,654,000USD | 94,163,000USD | 106,652,000USD | 101,534,000USD | 97,245,000USD | 96,830,000USD | 91,616,000USD |
| Cash And Equivalents | 16,160,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 58,362,000USD | 67,576,000USD | 80,237,000USD | 93,014,000USD | 87,492,000USD | 83,271,000USD | 81,954,000USD | 76,317,000USD |
| Other Non Current Assets | 190,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 21,231,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 11,396,000USD | 11,699,000USD | 15,148,000USD | 15,678,000USD | 15,531,000USD | 10,683,000USD | 14,967,000USD | 14,118,000USD |
| Other Current Liabilities | 6,690,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 48,788,000USD | 57,934,000USD | 67,480,000USD | 80,235,000USD | 74,845,000USD | 75,050,000USD | 70,019,000USD | 65,325,000USD |
| Total Equity Including Noncontrolling Interest | 48,594,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 9,480,000USD | 10,125,000USD | 10,383,000USD | 10,777,000USD | 11,098,000USD | 11,476,000USD | 11,859,000USD | 12,243,000USD |
| Accounts Payable | 3,242,000USD | 2,755,000USD | 3,891,000USD | 4,064,000USD | 3,881,000USD | 1,531,000USD | 4,323,000USD | 3,949,000USD |
| Short Term Debt | 946,000USD | 1,486,000USD | 1,466,000USD | 1,429,000USD | 1,331,000USD | 1,290,000USD | 1,252,000USD | 1,211,000USD |
| Common Stock | 98,000USD | 98,000USD | 98,000USD | 98,000USD | 93,000USD | 89,000USD | 84,000USD | 76,000USD |
| Retained Earnings | -627,264,000USD | -616,955,000USD | -606,164,000USD | -592,201,000USD | -566,457,000USD | -546,926,000USD | -532,046,000USD | -517,079,000USD |
| Accumulated Other Comprehensive Income | -68,000USD | -70,000USD | -8,000USD | -1,000USD | -75,000USD | -66,000USD | -40,000USD | 36,000USD |
| Other Current Assets | — | 586,000USD | 677,000USD | 1,770,000USD | 6,648,000USD | 5,934,000USD | 8,093,000USD | 8,499,000USD |
| Total Liab | — | 21,913,000USD | 26,875,000USD | 26,608,000USD | 26,878,000USD | 22,383,000USD | 26,998,000USD | 26,477,000USD |
| Other Current Liab | — | 7,458,000USD | 9,791,000USD | 10,185,000USD | 10,319,000USD | 7,862,000USD | 9,392,000USD | 8,958,000USD |
| Capital Stock | — | 98,000USD | 98,000USD | 98,000USD | 93,000USD | 89,000USD | 84,000USD | 76,000USD |
| Cash | — | 10,008,000USD | 10,743,000USD | 6,150,000USD | 17,220,000USD | 10,362,000USD | 11,055,000USD | 11,458,000USD |
| Cash And Short Term Investments | — | 66,513,000USD | 78,687,000USD | 90,202,000USD | 80,346,000USD | 76,349,000USD | 72,125,000USD | 65,987,000USD |
| Net Debt | — | 1,692,000USD | 1,290,000USD | 6,209,000USD | -4,542,000USD | 2,628,000USD | 2,228,000USD | 2,112,000USD |
| Short Long Term Debt Total | — | 11,700,000USD | 12,033,000USD | 12,359,000USD | 12,678,000USD | 12,990,000USD | 13,283,000USD | 13,570,000USD |
| Short Term Investments | — | 56,505,000USD | 67,944,000USD | 84,052,000USD | 63,126,000USD | 65,987,000USD | 61,070,000USD | 54,529,000USD |
| Net Receivables | — | 477,000USD | 873,000USD | 1,042,000USD | 498,000USD | 988,000USD | 1,736,000USD | 1,831,000USD |
| Property Plant Equipment Gross | — | 10,125,000USD | 15,211,000USD | 10,777,000USD | 11,098,000USD | 11,476,000USD | 16,401,000USD | 12,243,000USD |
| Common Stock Shares Outstanding | — | 98,043,839shares | 98,010,084shares | 97,153,541shares | 90,120,235shares | 86,485,126shares | 82,724,659shares | 75,801,666shares |
| Non Current Assets Total | — | 12,078,000USD | 13,926,000USD | 13,638,000USD | 14,042,000USD | 13,974,000USD | 14,876,000USD | 15,299,000USD |
| Non Current Liabilities Total | — | 10,214,000USD | 11,727,000USD | 10,930,000USD | 11,347,000USD | 11,700,000USD | 12,031,000USD | 12,359,000USD |
| Non Currrent Assets Other | — | 148,000USD | 1,308,000USD | 149,000USD | 2,944,000USD | 2,498,000USD | 3,017,000USD | 3,056,000USD |
| Net Working Capital | — | 55,877,000USD | 65,089,000USD | 77,336,000USD | 71,961,000USD | 72,588,000USD | 66,987,000USD | 62,199,000USD |
| Unclassified Non Current Assets | — | 1,805,000USD | 2,235,000USD | 2,712,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | 10,214,000USD | 11,727,000USD | 10,930,000USD | 11,347,000USD | 11,700,000USD | 12,031,000USD | 12,359,000USD |
| Unclassified Equity | — | 674,763,000USD | 673,456,000USD | 672,241,000USD | 641,191,000USD | 621,864,000USD | 601,937,000USD | 582,216,000USD |
| Source | 0001339970-26-000053DeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 94,163,000USD | 96,830,000USD | 120,653,000USD | 95,786,000USD | 115,537,000USD | 38,726,000USD | 36,188,000USD | 52,746,000USD |
| Other Current Assets | 677,000USD | 8,093,000USD | 2,390,000USD | 2,950,000USD | 5,223,000USD | 1,803,000USD | 681,000USD | 1,258,000USD |
| Total Liab | 26,875,000USD | 26,998,000USD | 30,183,000USD | 24,502,000USD | 6,411,000USD | 7,242,000USD | 15,162,000USD | 19,096,000USD |
| Total Stockholder Equity | 67,480,000USD | 70,019,000USD | 90,658,000USD | 71,464,000USD | 109,301,000USD | 31,650,000USD | 21,186,000USD | 33,650,000USD |
| Other Current Liab | 9,791,000USD | 9,392,000USD | 11,559,000USD | 9,862,000USD | 4,002,000USD | 3,572,000USD | 2,376,000USD | 2,026,000USD |
| Common Stock | 98,000USD | 84,000USD | 63,000USD | 29,000USD | 28,000USD | 11,000USD | 4,000USD | 31,000USD |
| Capital Stock | 98,000USD | 84,000USD | 63,000USD | 29,000USD | 28,000USD | 11,000USD | — | — |
| Retained Earnings | -606,164,000USD | -532,046,000USD | -468,023,000USD | -417,634,000USD | -372,296,000USD | -338,528,000USD | -322,304,000USD | -298,701,000USD |
| Cash | 10,743,000USD | 11,055,000USD | 22,544,000USD | 9,981,000USD | 2,336,000USD | 16,952,000USD | 9,210,000USD | 22,962,000USD |
| Cash And Short Term Investments | 78,687,000USD | 72,125,000USD | 98,166,000USD | 66,146,000USD | 107,911,000USD | 31,689,000USD | 31,144,000USD | 49,545,000USD |
| Total Current Assets | 80,237,000USD | 81,954,000USD | 102,992,000USD | 80,871,000USD | 113,569,000USD | 35,531,000USD | 31,925,000USD | 50,803,000USD |
| Total Current Liabilities | 15,148,000USD | 14,967,000USD | 16,416,000USD | 13,862,000USD | 6,013,000USD | 5,864,000USD | 12,923,000USD | 10,833,000USD |
| Net Debt | 1,290,000USD | 2,228,000USD | -7,449,000USD | 1,553,000USD | -958,000USD | -14,713,000USD | 2,521,000USD | -6,932,000USD |
| Short Term Debt | 1,466,000USD | 1,252,000USD | 1,328,000USD | 894,000USD | 980,000USD | 861,000USD | 9,492,000USD | 7,767,000USD |
| Short Long Term Debt Total | 12,033,000USD | 13,283,000USD | 15,095,000USD | 11,534,000USD | 1,378,000USD | 2,239,000USD | 11,731,000USD | 16,030,000USD |
| Short Term Investments | 67,944,000USD | 61,070,000USD | 75,622,000USD | 56,165,000USD | 105,575,000USD | 14,737,000USD | 21,934,000USD | 26,583,000USD |
| Net Receivables | 873,000USD | 1,736,000USD | 2,436,000USD | 11,775,000USD | 435,000USD | 2,039,000USD | 100,000USD | — |
| Accounts Payable | 3,891,000USD | 4,323,000USD | 3,529,000USD | 3,106,000USD | 1,031,000USD | 1,431,000USD | 847,000USD | 1,040,000USD |
| Property Plant Equipment Net | 10,383,000USD | 11,859,000USD | 14,046,000USD | 11,557,000USD | 1,810,000USD | 2,982,000USD | 4,091,000USD | 1,853,000USD |
| Property Plant Equipment Gross | 15,211,000USD | 16,401,000USD | 18,667,000USD | 17,911,000USD | 7,967,000USD | 9,606,000USD | — | — |
| Accumulated Other Comprehensive Income | -8,000USD | -40,000USD | -74,000USD | -433,000USD | -263,000USD | -43,000USD | -40,000USD | -60,000USD |
| Common Stock Shares Outstanding | 92,985,359shares | 74,261,265shares | 53,606,488shares | 28,419,569shares | 19,080,878shares | 9,160,269shares | 3,355,600shares | 2,139,792shares |
| Non Current Assets Total | 13,926,000USD | 14,876,000USD | 17,661,000USD | 14,915,000USD | 1,968,000USD | 3,195,000USD | 4,263,000USD | 1,943,000USD |
| Non Current Liabilities Total | 11,727,000USD | 12,031,000USD | 13,767,000USD | 10,640,000USD | 398,000USD | 1,378,000USD | 2,239,000USD | 8,263,000USD |
| Non Currrent Assets Other | 1,308,000USD | 3,017,000USD | 3,615,000USD | 3,358,000USD | 158,000USD | 213,000USD | 172,000USD | 90,000USD |
| Net Working Capital | 65,089,000USD | 66,987,000USD | 86,576,000USD | 67,009,000USD | 107,556,000USD | 29,667,000USD | — | — |
| Unclassified Non Current Assets | 2,235,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | 11,727,000USD | 12,031,000USD | 13,767,000USD | 10,640,000USD | — | 1,378,000USD | 2,239,000USD | 8,263,000USD |
| Unclassified Equity | 673,456,000USD | 601,937,000USD | 558,629,000USD | 489,473,000USD | 481,804,000USD | 370,199,000USD | 343,526,000USD | 332,380,000USD |
| Other Assets | — | — | 1USD | — | — | — | — | — |
| Current Deferred Revenue | — | — | — | — | 1USD | — | 208,000USD | — |
| Short Long Term Debt | — | — | — | — | — | — | 8,737,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | — | -8,737,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 330,000USD |
| Change To Liabilities | -3,733,000USD |
| Change In Working Capital | -3,624,000USD |
| Operating Cash Flow | -21,868,000USD |
| Capital Expenditures | -211,000USD |
| Net Investments | 27,027,000USD |
| Investing Cash Flow | 26,816,000USD |
| Net Debt Issuance | -287,000USD |
| Common Stock Issuance | 0USD |
| Unclassified Financing Cash Flow | 16,000USD |
| Financing Cash Flow | -271,000USD |
| Change In Cash | 4,677,000USD |
| End Cash Flow | 17,655,000USD |
| Source | 0001339970-26-000053DeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -10,792,000USD | -13,964,000USD | -25,746,000USD | -19,532,000USD | -14,881,000USD | -14,968,000USD | -17,259,000USD | -16,306,000USD |
| Depreciation | 394,000USD | 394,000USD | 389,000USD | 387,000USD | 383,000USD | -1,000USD | 388,000USD | 383,000USD |
| Stock Based Compensation | 1,307,000USD | 1,207,000USD | 1,307,000USD | 1,305,000USD | 1,178,000USD | 770,000USD | 752,000USD | 727,000USD |
| Other Non Cash Items | -255,000USD | -373,000USD | -512,000USD | -458,000USD | -523,000USD | -553,000USD | -611,000USD | -735,000USD |
| Change To Account Receivables | 396,000USD | 169,000USD | -544,000USD | 490,000USD | 748,000USD | 95,000USD | -203,000USD | 56,000USD |
| Change In Working Capital | -3,171,000USD | 540,000USD | 4,086,000USD | 4,404,000USD | -1,577,000USD | 1,620,000USD | 3,572,000USD | -4,518,000USD |
| Total Cash From Operating Activities | -12,517,000USD | -12,196,000USD | -20,476,000USD | -13,894,000USD | -15,420,000USD | -13,132,000USD | -13,158,000USD | -20,449,000USD |
| Capital Expenditures | -138,000USD | -31,000USD | -37,000USD | -9,000USD | 0USD | -25,000USD | -15,000USD | -8,000USD |
| Free Cash Flow | -12,655,000USD | -12,227,000USD | -20,513,000USD | -13,903,000USD | -15,420,000USD | -13,157,000USD | -13,173,000USD | -20,457,000USD |
| Investments | 11,632,000USD | 16,462,000USD | -20,377,000USD | 3,301,000USD | -4,420,000USD | -6,085,000USD | 17,946,000USD | 6,728,000USD |
| Total Cashflows From Investing Activities | 11,494,000USD | 16,443,000USD | -20,377,000USD | 3,301,000USD | -4,420,000USD | -6,085,000USD | 17,946,000USD | 6,728,000USD |
| Net Borrowings | -142,000USD | -139,000USD | -136,000USD | -133,000USD | -131,000USD | -128,000USD | -125,000USD | — |
| Total Cash From Financing Activities | -142,000USD | -131,000USD | 29,617,000USD | 17,897,000USD | 18,628,000USD | 18,839,000USD | -105,000USD | 13,400,000USD |
| Issuance Of Capital Stock | 0USD | -21,000USD | 29,753,000USD | 17,932,000USD | 18,759,000USD | 18,906,000USD | 20,000USD | 13,484,000USD |
| Change In Cash | -1,165,000USD | 4,116,000USD | -11,236,000USD | 7,304,000USD | -1,212,000USD | -378,000USD | 4,683,000USD | -321,000USD |
| Begin Period Cash Flow | 12,978,000USD | 8,862,000USD | 20,098,000USD | 12,794,000USD | 14,006,000USD | 14,384,000USD | 9,701,000USD | 10,022,000USD |
| End Period Cash Flow | 11,813,000USD | 12,978,000USD | 8,862,000USD | 20,098,000USD | 12,794,000USD | 14,006,000USD | 14,384,000USD | 9,701,000USD |
| Other Cashflows From Investing Activities | 255,000USD | 12,000USD | 6,054,000USD | 981,000USD | — | 7,000USD | — | — |
| Other Cashflows From Financing Activities | -142,000USD | — | 24,827,000USD | 98,000USD | — | 61,000USD | 17,946,000USD | 39,000USD |
| Sale Purchase Of Stock | — | — | 40,000USD | 79,000USD | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | -6,017,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 4,886,000USD | 17,853,000USD | — | — | -17,946,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -74,123,000USD | -64,023,000USD | -50,389,000USD | -45,343,000USD | -33,768,000USD | -16,224,000USD | -23,763,000USD | -34,515,000USD |
| Depreciation | 1,553,000USD | 1,540,000USD | 2,741,000USD | 1,695,000USD | 1,304,000USD | 1,266,000USD | 1,366,000USD | 746,000USD |
| Stock Based Compensation | 4,997,000USD | 2,989,000USD | 2,600,000USD | 2,154,000USD | 1,614,000USD | 1,465,000USD | 1,783,000USD | — |
| Other Non Cash Items | -1,866,000USD | -2,707,000USD | -3,185,000USD | 441,000USD | 363,000USD | 453,000USD | 395,000USD | 7,704,000USD |
| Change To Account Receivables | 863,000USD | 402,000USD | 9,054,000USD | -11,923,000USD | 1,604,000USD | -1,939,000USD | 58,000USD | — |
| Change In Working Capital | 7,453,000USD | -6,918,000USD | 15,012,000USD | -833,000USD | -2,588,000USD | -2,261,000USD | 206,000USD | -1,448,000USD |
| Total Cash From Operating Activities | -61,986,000USD | -69,119,000USD | -33,221,000USD | -41,886,000USD | -33,075,000USD | -15,301,000USD | -20,013,000USD | -31,063,000USD |
| Capital Expenditures | -77,000USD | -65,000USD | -4,215,000USD | -1,641,000USD | -192,000USD | -202,000USD | -79,000USD | -594,000USD |
| Free Cash Flow | -62,063,000USD | -69,184,000USD | -37,436,000USD | -43,527,000USD | -33,267,000USD | -15,503,000USD | -20,092,000USD | -31,657,000USD |
| Investments | -4,988,000USD | 17,233,000USD | -20,127,000USD | 47,245,000USD | -91,566,000USD | 6,900,000USD | — | — |
| Total Cashflows From Investing Activities | -5,053,000USD | 17,233,000USD | -20,127,000USD | 47,245,000USD | -91,566,000USD | 6,900,000USD | 4,925,000USD | 37,172,000USD |
| Net Borrowings | -539,000USD | -497,000USD | -394,000USD | -66,000USD | 0USD | — | — | — |
| Total Cash From Financing Activities | 66,011,000USD | 39,864,000USD | 66,230,000USD | 5,451,000USD | 110,025,000USD | 16,143,000USD | 1,336,000USD | -4,238,000USD |
| Issuance Of Capital Stock | 66,423,000USD | 40,261,000USD | 66,519,000USD | 5,472,000USD | 109,952,000USD | 25,216,000USD | — | — |
| Change In Cash | -1,028,000USD | -12,022,000USD | 12,882,000USD | 10,810,000USD | -14,616,000USD | 7,742,000USD | -13,752,000USD | 1,871,000USD |
| Begin Period Cash Flow | 14,006,000USD | 26,028,000USD | 13,146,000USD | 2,336,000USD | 16,952,000USD | 9,210,000USD | 22,962,000USD | 21,091,000USD |
| End Period Cash Flow | 12,978,000USD | 14,006,000USD | 26,028,000USD | 13,146,000USD | 2,336,000USD | 16,952,000USD | 9,210,000USD | 22,962,000USD |
| Other Cashflows From Investing Activities | 1,854,000USD | 7,000USD | 15,000USD | 179,000USD | -91,374,000USD | 7,102,000USD | 51,000USD | — |
| Unclassified Investing Cash Flow | -1,842,000USD | — | 4,200,000USD | 1,462,000USD | 91,566,000USD | -6,900,000USD | 4,953,000USD | 37,766,000USD |
| Other Cashflows From Financing Activities | — | 100,000USD | 105,000USD | 45,000USD | 73,000USD | 10,000USD | 13,000USD | 50,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | -9,083,000USD | 1,323,000USD | -4,288,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -3,550,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.